Policy statement--recommendations for the prevention and treatment of influenza in children, 2009 -2010.
The purpose of this statement is to update current recommendations for routine use of trivalent seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children.
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003140:Communicable Disease Control / Q000592:standards*; D004356:Drug Storage; D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control; D005260:Female; D006801:Humans; D017589:Immunization Programs / Q000592:standards*; D007223:Infant; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology; D053122:Influenza A Virus, H3N2 Subtype / Q000276:immunology; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D007251:Influenza, Human / Q000188:drug therapy / Q000517:prevention & control*; D008297:Male; D011050:Policy Making; D018570:Risk Assessment; D014481:United States; D014486:United States Food and Drug Administration; D014611:Vaccination / Q000592:standards; D014613:Vaccines, Attenuated / Q000008:administration & dosage
D007252:Influenza Vaccines; D014613:Vaccines, Attenuated